NEW YORK (GenomeWeb) – Startup company Viome announced today that it has raised $15 million in Series A funding to support the launch of its at-home human microbiome testing kit.

The company is currently functioning in beta mode, with thousands of customers using the product.

Viome's first round of venture capital financing was led by Khosla Ventures, with participation from Bold Capital partners. Khosla Ventures, led by managing partner Vinod Khoshla, will receive one seat on Viome's board. The company also noted it has now raised a total of $21 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.